HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

SCCNFP Hair Dye Safety Assessments Require Additional Data

This article was originally published in The Rose Sheet

Executive Summary

The European Union Scientific Committee on Cosmetic Products and Non-Food Products needs additional data on eight hair dye ingredients before concluding safety assessments on the substances, the advisory group states in separate opinions

You may also be interested in...



SCCP Concludes Additional Data Is Needed On Hair Dye, UV Filters

An in vitro percutaneous absorption study under oxidative conditions is among the data needed to determine the safety of hair dye ingredient 1-hydroxyethyl-4,5-diamino pyrazole sulfate, the EU's Scientific Committee on Consumer Products concludes in an 1opinion adopted during its June 20 plenary session

SCCP Concludes Additional Data Is Needed On Hair Dye, UV Filters

An in vitro percutaneous absorption study under oxidative conditions is among the data needed to determine the safety of hair dye ingredient 1-hydroxyethyl-4,5-diamino pyrazole sulfate, the EU's Scientific Committee on Consumer Products concludes in an 1opinion adopted during its June 20 plenary session

Bergamottin Cosmetics Ban Reaffirmed In SCCNFP Opinion

Inadequate safety data exist on the phototoxic potential of bergamottin to permit the perfumery material's use in cosmetics without restrictions, the European Union Scientific Committee on Cosmetic Products and Non-Food Products concludes in a recently released 1opinion

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011846

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel